Important Innovations

  COVID Vaccines Very Close to Market                                             Source:  Moderna Hope For a COVID Weary World Moderna, headquartered in Cambridge, MA, is seeking US, EU and UK emergency authorization for their COVID vaccine.  The vaccine has proved to be 94% effective.  The company adds it has no serious side effects. Highly Effective More than 1.5 million people have died from COVID.  Moderna says the vaccine is 100% effective in preventing severe cases of COVID.  It also works across demographic groups, including age, gender, ethnicity and race. Second COVID Vaccine Close to Market This is the second vaccine that is now under review for emergency authorization.  The other vaccine was developed by Pfizer and its German biotech partner BioNTech.  That vaccine is 95%.  Both the Pfizer and the Moder...

  Pfizer To Request Quick Emergency FDA Approval Source:  Pfizer COVID Vaccine Suddenly There Is Hope    Pfizer has completed its late stage trial of its COVID-19 vaccine, saying it is 95% effective.  The company adds that it is effective on older adults, who are more vulnerable, and works against both mild and severe cases of COVID.  The company has the required 2 months of safety data for regulators.  Within days, Pfizer says it will apply for emergency FDA approval to start making it available for public use.  The vaccine's efficacy rate is the highest among all current vaccine candidate now in trials.  As the Economist magazine put it "Suddenly There is Hope". "The Speed of Science" Pfizer expects that the FDA will hold a public hearing on their vaccine in December.  Pfizer CEO Albert Bourla says knowing that every day matters in the fight against COVID, the company is moving at what he calls "the speed of science".  The vaccine...